Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

51.8K
Overview
51.8K
Cancer Vaccines01:30

Cancer Vaccines

1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

281
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
281
Hepatic Portal System01:21

Hepatic Portal System

6.2K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
6.2K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

248
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
248
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

599
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
599

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diradical dications of electron-enriched sulfur-bridged dihydrophenazine derivatives.

Chemical communications (Cambridge, England)·2026
Same author

Light-Controlled Topology Switching Enables Continuous Modulation of Thermally Induced Phase Behavior in Polymer Solutions.

ACS macro letters·2026
Same author

Brain cortex activity of patients with disorders of consciousness under familiar and unfamiliar voice of subject's own name: an fNIRS-based study.

Frontiers in neurology·2026
Same author

Low-complexity mitigation of multipath interference in PAM-4 IM/DD systems via recursive filtering.

Optics express·2026
Same author

Assessing the Alignment of Long-Term Care Insurance Benefits and Service Provision: Evidence from Shandong, China and Implications for Implementation Risk.

Risk management and healthcare policy·2026
Same author

A persistent germylyne radical enabling reversible σ-dimerization and diverse bond activation.

Nature communications·2026

Related Experiment Video

Updated: Feb 11, 2026

Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications
07:23

Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications

Published on: October 20, 2023

1.9K

Development of new hepatitis E vaccines.

Yufeng Cao1,2, Zhenhong Bing3, Shiyu Guan3

  • 1a College of Veterinary Medicine, Jilin University , Changchun , Jilin , PR China.

Human Vaccines & Immunotherapeutics
|May 1, 2018
PubMed
Summary

Hepatitis E virus (HEV) infection is a global health concern, particularly for pregnant women. The Hecolin® vaccine is currently the only licensed vaccine for HEV prevention, showing promising safety and efficacy.

Keywords:
AdvanceHEVHepatitis EVaccine

More Related Videos

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

14.0K
Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
10:03

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Published on: August 1, 2013

17.6K

Related Experiment Videos

Last Updated: Feb 11, 2026

Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications
07:23

Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications

Published on: October 20, 2023

1.9K
Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

14.0K
Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
10:03

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Published on: August 1, 2013

17.6K

Area of Science:

  • Virology
  • Immunology
  • Public Health

Background:

  • Hepatitis E virus (HEV) is an emerging zoonotic pathogen with significant global public health implications.
  • HEV infection poses a severe threat, especially to pregnant women, and lacks specific antiviral treatments.
  • Development of an effective vaccine is critical for controlling HEV transmission and disease.

Observation:

  • Several HEV vaccine candidates have been investigated for their immunogenicity and efficacy.
  • Hecolin®, developed by Xiamen Innovax Biotech Co., Ltd., received approval from the China Food and Drug Administration (CFDA) in 2012.
  • Hecolin® is the sole licensed HEV vaccine globally to date.

Findings:

  • Phase III clinical trials demonstrated the safety, immunogenicity, and efficacy of Hecolin®.
  • The vaccine shows significant potential for HEV prevention and control strategies.
  • Ongoing research continues to advance HEV vaccine development.

Implications:

  • The availability of a licensed HEV vaccine offers a crucial tool for public health interventions.
  • Hecolin® provides a viable option for reducing the burden of Hepatitis E, particularly in at-risk populations.
  • Further research into HEV vaccines can lead to improved global health outcomes and disease management.